DSS INC.
BIOTECHNOLOGY
INVESTMENT HOLDING COMPANY
DSS focuses on operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. The DSS business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs.
BIOTECHNOLOGY
Engaged in advancing biopharmaceutical technologies with potential to advance treatment in oncology, neurology, and immunology. Consumer products include naturally based sugar alternatives, fragrances, and insect repellents, as well as antibacterial, antiviral, and antimicrobial technologies.
MOSQUITO TECHNOLOGY
Functional Fragrance Formulation (“3F”)
3F (Functional Fragrance Formulation) is a unique formulation of specialized ingredients (e.g. terpenes) from botanical sources with demonstrated effect as an insect repellent and an antimicrobial.
PANDEMIC RESEARCH
Equivir​
Equivir technology is a novel blend of FDA Generally Recognized as Safe (GRAS) eligible polyphenols that have proven antiviral effects with additional potential applications such as medication or supplements.
LINEBACKER PLATFORM
LineBacker​
LineBacker is a platform for small molecule X-bonded polyphenols, which enhance potency, efficacy, bioavailability, and permeability while ensuring safety and tolerability.
ALTERNATIVE SUGAR
Laetose​
Laetose technology is derived from a unique combination of sugar and inositol, which has the potential ability to inhibit the inflammatory and metabolic response of sugar alone.